EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Encapsulation of Carvedilol in Nanomicelles Improves Central Hemodynamics and Target Organ Damage Protection in Spontaneously Hypertensive Rats

Luciano Parola, Paula Denise Prince, Javier Alberto Walter Opezzo, Jennifer Riedel, Miguel Ángel Allo, Yanina Alejandra Santander Plantamura, Eliana P Bin, Germán E González, Andrea Carranza, Martín Donato, Diego A Chiappetta, Marcela A Moretton und 1 weitere

Pharmacology Research & Perspectives · 2025

DOI: 10.1002/prp2.70125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, 2025. Verfasst von Luciano Parola und 12 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Farmacología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Carvedilol, Hypertension, Antihypertensive Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaría de Ciencia y Técnica, Universidad de Buenos Aires.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The hypothesis of this work was that chronic treatment with carvedilol (CAR) administered in a nanomicelles‐based formulation (CAR‐NMs), which increases CAR oral bioavailability, is more effective than a conventional liquid CAR formulation (CAR‐LCF) and is comparable to chronic treatment with losartan (LOS) in improving hemodynamic parameters and preventing target organ damage (TOD) in spontaneously hypertensive (SH) rats. Chronic treatment with CAR‐NMs significantly improved central hemodynamic parameters (systolic and diastolic blood pressure (BP) and its variability) to a similar extent as LOS, and with superior efficacy than CAR‐LCF. Although LOS was more effective than CAR‐NMs and CAR‐LCF in reducing peripheral systolic BP, both LOS and CAR‐NMs, in contrast to CAR‐LCF, were able to significantly reduce short‐term BP variability indexes. Both CAR formulations and LOS significantly reduced aortic media wall thickness and interstitial collagen deposition, and lowered TNF‐α expression in left ventricle (LV) in SH rats. Only CAR‐NMs significantly reduced IL‐6 expression and were more effective in reducing ventricular TGF‐β expression in LV of SH rats. These findings suggest that encapsulation of CAR in NMs improved its ability to control central hemodynamics in SH rats when compared with CAR‐LCF, mainly due to a greater effect on carotid systolic BP and short‐term BP variability, resulting in a higher protection against TOD compared to CAR‐LCF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarvedilolHypertensionAntihypertensive AgentsAnimalsMaleRats, Inbred SHRRatsHemodynamicsMicellesBlood PressureLosartanNanoparticles

Stichwörter der Autor:innen

blood pressure variabilitycarvedilolcentral blood pressurehypertensionlosartannanomicellestarget organ damage

Substanzen

CarvedilolMicellesAntihypertensive AgentsLosartan

Autor:innen und Institutionen

  • Departamento de Farmacología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Instituto de Tecnología Farmacéutica y Biofarmacia (InTecFyB), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Instituto Alberto C. Taquini de Investigaciones en Medicina Traslacional (CONICET), Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Departamento de Tecnología Farmacéutica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Instituto de Fisiopatología Cardiovascular (INFICA), Departamento de Patología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Laboratorio de Patología Cardiovascular Experimental e Hipertensión Arterial, Instituto de Investigaciones Biomédicas (BIOMED UCA-CONICET), Buenos Aires, Argentina.

ORCID-Profile: Christian Höcht

Förderung

  • Secretaría de Ciencia y Técnica, Universidad de Buenos Aires

Zitieren

APA

Parola, L., Prince, P. D., Opezzo, J. A. W., Riedel, J., Allo, M. Á., Santander Plantamura, Y. A., Bin, E. P., González, G. E., Carranza, A., Donato, M., Chiappetta, D. A., Moretton, M. A., & Höcht, C. (2025). Encapsulation of Carvedilol in Nanomicelles Improves Central Hemodynamics and Target Organ Damage Protection in Spontaneously Hypertensive Rats. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70125

Vancouver

Parola L, Prince PD, Opezzo JAW, Riedel J, Allo MÁ, Santander Plantamura YA, et al. Encapsulation of Carvedilol in Nanomicelles Improves Central Hemodynamics and Target Organ Damage Protection in Spontaneously Hypertensive Rats. Pharmacology Research & Perspectives. 2025. doi:10.1002/prp2.70125

BibTeX
@article{Parola2025,
  author = {Parola, Luciano and Prince, Paula Denise and Opezzo, Javier Alberto Walter and Riedel, Jennifer and Allo, Miguel Ángel and Santander Plantamura, Yanina Alejandra and Bin, Eliana P and González, Germán E and Carranza, Andrea and Donato, Martín and Chiappetta, Diego A and Moretton, Marcela A and Höcht, Christian},
  title = {Encapsulation of Carvedilol in Nanomicelles Improves Central Hemodynamics and Target Organ Damage Protection in Spontaneously Hypertensive Rats},
  journal = {Pharmacology Research & Perspectives},
  year = {2025},
  doi = {10.1002/prp2.70125}
}
Kostenlos starten →